HomeIPH • EPA
add
Innate Pharma SA
Previous close
€1.72
Day range
€1.74 - €1.86
Year range
€1.33 - €2.79
Market cap
151.05M EUR
Avg Volume
107.09K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 3.89M | -63.74% |
Operating expense | 5.07M | 10.83% |
Net income | -12.35M | -166.01% |
Net profit margin | -317.73 | -633.62% |
Earnings per share | — | — |
EBITDA | -12.01M | -131.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 80.77M | -12.64% |
Total assets | 111.06M | -39.71% |
Total liabilities | 102.22M | -22.73% |
Total equity | 8.83M | — |
Shares outstanding | 81.23M | — |
Price to book | 15.62 | — |
Return on assets | -28.43% | — |
Return on capital | -79.28% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -12.35M | -166.01% |
Cash from operations | -4.97M | 52.91% |
Cash from investing | 4.13M | -60.40% |
Cash from financing | -840.50K | -133.47% |
Net change in cash | -1.80M | -344.80% |
Free cash flow | -6.99M | -149.30% |
About
Founded
1999
Website
Employees
181